Pipeline

Five Prime is pursuing discovery and clinical development of its product candidates both independently and in collaboration with pharmaceutical partners. We are focused primarily on therapies for cancer and have three drug candidates in active human clinical trials.  We are also focusing our earlier stage research efforts on immuno-oncology.

We are currently focused on therapies for cancer and inflammatory diseases for our own pipeline. Three drug candidates in these areas have progressed into active human clinical trials.  We are also focusing our earlier stage research efforts on immuno-oncology.